|
|
||||||||
Regular Article |
Received September 23, 2004; revised March 9, 2005; accepted March 10, 2005. From the Dept. of Psychiatry (CSC), the Dept. of Internal Medicine (JCT), the Dept. of Medical Imaging (YTK, ICC), the Dept. of Neurology (HFL), Kaohsiung Medical University, Kaohsiung, Taiwan, the Dept. of Psychiatry, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan (CSC), the Dept. of Biological Psychiatry, New York State Psychiatric Institute and the College of Physicians and Surgeons of Columbia University, New York, NY (CSC, DPD), and the Dept. of Psychiatry, Chang Gung Memorial Hospital at Chia Yi, Taiwan (HYT). Send correspondence and reprint requests to Cheng-Sheng Chen, M.D., Dept. of Psychiatry, Kaohsiung Medical University, Chung-Ho Memorial Hospital, No. 100, Tzyou 1st Rd, Kaohsiung City, Taiwan 807. e-mail: sheng{at}cc.kmu.edu.tw
© 2005 American Association for Geriatric Psychiatry
Objective: Epidemiological studies suggest that elevated plasma homocysteine is associated with an increased risk of depression and cerebrovascular disease. There are no published reports of homocysteine levels and methylenetetrahydrofolate reductase (MTHFR) C677T genotype in clinical samples of patients with late-onset major depressive disorder (MDD). The purpose of this study was to examine the association of homocysteine levels or MTHFR C677T genotype and late-onset MDD and assess whether this may be affected by brain magnetic resonance imaging (MRI) hyperintensities. Methods: Authors recruited 39 elderly patients with MDD with first episode occurring after age 50 and 20 comparison subjects and assessed total plasma homocysteine levels, MTHFR genotype, and brain MRIs. Results: Plasma total homocysteine levels were higher in elderly patients with late-onset MDD versus comparison subjects. The association did not change after controlling for MRI hyperintensities, and the distribution of MTHFR C677T genotype was not different between the groups. Conclusions: In this exploratory study, elevated homocysteine levels were associated with late-onset MDD, and the association did not appear to be mediated by vascular pathology as identified by brain MRI hyperintensities.
Key Words: Depression Genetic Factors MRI Studies Homocysteine
This article has been cited by other articles:
![]() |
F. A. Kozel, M. H. Trivedi, S. R. Wisniewski, S. Miyahara, M. M. Husain, M. Fava, B. Lebowitz, S. Zisook, and A. J. Rush Treatment Outcomes for Older Depressed Patients With Earlier Versus Late Onset of First Depressive Episode: A Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Report Am J Geriatr Psychiatry, January 1, 2008; 16(1): 58 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gilbody, T. Lightfoot, and T. Sheldon Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity J. Epidemiol. Community Health, July 1, 2007; 61(7): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gilbody, S. Lewis, and T. Lightfoot Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE Review Am. J. Epidemiol., January 1, 2007; 165(1): 1 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Steffens Research in Geriatric Depression: A Model for Mental Health Research in the 21st Century? Am J Geriatr Psychiatry, October 1, 2005; 13(10): 829 - 833. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |